Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C5H11NO2Se |
| Molecular Weight | 196.11 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[Se]CC[C@H](N)C(O)=O
InChI
InChIKey=RJFAYQIBOAGBLC-BYPYZUCNSA-N
InChI=1S/C5H11NO2Se/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1
| Molecular Formula | C5H11NO2Se |
| Molecular Weight | 196.11 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/12656658 | https://examine.com/supplements/selenium
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/12656658 | https://examine.com/supplements/selenium
L-isomer of selenomethionine (Se-met) is a major natural food-form of selenium, synthetic L-Se-met or enriched food sources thereof such as selenium yeast are appropriate supplemental forms of Se for humans; for animals, DL-Se-met is acceptable. Ingested Se-met is either metabolized directly to reactive forms of selenium or stored in place of methionine in body proteins. Se-met metabolism is closely linked to protein turnover. Selenium, which is nutritionally essential for humans, is a constituent of more than two dozen selenoproteins that play critical roles in reproduction, thyroid hormone metabolism, DNA synthesis, and protection from oxidative damage and infection.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: WP408 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10867031 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Preventing | Selenium (selenomethionine) Approved UseSelenium (selenomethionine) is a natural antioxidant that delays the oxidation of polyunsaturated fatty acids and preserves the elasticity of tissue. Selenium is required for the production of certain prostaglandins, which promote healthy blood flow. In synergy with vitamin E, selenium promotes healthy growth and fertility, and improves the function of certain energy producing cells. Selenium also provides support for the immune system |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of selenomethionine supplementation in food on the excretion and toxicity of arsenic exposure in female mice. | 2013-12 |
|
| Effects of chronic dietary selenomethionine exposure on repeat swimming performance, aerobic metabolism and methionine catabolism in adult zebrafish (Danio rerio). | 2013-04-15 |
|
| Major differences among chemopreventive organoselenocompounds in the sustained elevation of cytoprotective genes. | 2012-09 |
|
| Induction of oxidative stress by selenomethionine in isolated hepatocytes of rainbow trout (Oncorhynchus mykiss). | 2012-06 |
|
| Attenuation of the cortisol response to stress in female rainbow trout chronically exposed to dietary selenomethionine. | 2011-10 |
|
| Chronic exposure to dietary selenomethionine increases gonadal steroidogenesis in female rainbow trout. | 2011-10 |
|
| Induction of ROS, p53, p21 in DEHP- and MEHP-exposed LNCaP cells-protection by selenium compounds. | 2011-07 |
|
| Low levels of selenium compounds are selectively toxic for a human neuron cell line through ROS/RNS increase and apoptotic process activation. | 2011-03 |
|
| Evaluation of cytotoxicity and oxidative DNA damaging effects of di(2-ethylhexyl)-phthalate (DEHP) and mono(2-ethylhexyl)-phthalate (MEHP) on MA-10 Leydig cells and protection by selenium. | 2010-10-01 |
|
| Inhibition of apoptotic signalling in spermine-treated vascular smooth muscle cells by a novel glutathione precursor. | 2010-04-01 |
|
| Regulation of cellular glutathione peroxidase by different forms and concentrations of selenium in primary cultured bovine hepatocytes. | 2010-02 |
|
| Selenomethionine stimulates expression of glutathione peroxidase 1 and 3 and growth of bovine mammary epithelial cells in primary culture. | 2009-06 |
|
| Characteristics of transport of selenoamino acids by epithelial amino acid transporters. | 2009-02-12 |
|
| Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells. | 2008-11 |
|
| Effects of naturally occurring and synthetic organoselenium compounds on protein profiling in androgen responsive and androgen independent human prostate cancer cells. | 2008 |
|
| Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells. | 2007-04-01 |
|
| Molecular mechanisms of the chemopreventive effect on hepatocellular carcinoma development in Mdr2 knockout mice. | 2007-04 |
|
| Seleno-L-methionine protects against beta-amyloid and iron/hydrogen peroxide-mediated neuron death. | 2007-04 |
|
| Selenomethionine induced transcriptional programs in human prostate cancer cells. | 2007-02 |
|
| Selenomethionine inhibits ultraviolet radiation-induced p53 transactivation. | 2006-12 |
|
| The crystal structure of iron-free human serum transferrin provides insight into inter-lobe communication and receptor binding. | 2006-08-25 |
|
| Selenium- or quercetin-induced retardation of DNA synthesis in primary prostate cells occurs in the presence of a concomitant reduction in androgen-receptor activity. | 2006-07-28 |
|
| Selenium long-term administration and its effect on mercury toxicity. | 2006-06-14 |
|
| Involvement of selenoprotein P in protection of human astrocytes from oxidative damage. | 2006-05-01 |
|
| Double-stranded RNA-dependent protein kinase (PKR) is a stress-responsive kinase that induces NFkappaB-mediated resistance against mercury cytotoxicity. | 2006-03-13 |
|
| Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes. | 2005-10 |
|
| Selenium metabolites in human urine after ingestion of selenite, L-selenomethionine, or DL-selenomethionine: a quantitative case study by HPLC/ICPMS. | 2005-09 |
|
| Interaction of selenium compounds with zinc finger proteins involved in DNA repair. | 2004-08 |
|
| Analysis of organoselenium compounds in human urine using active carbon and chemically modified silica sol-gel surface-assisted laser desorption/ionization high-resolution time-of-flight mass spectrometry. | 2004-04-01 |
|
| Selenium-containing compounds attenuate peroxynitrite-mediated NF-kappaB and AP-1 activation and interleukin-8 gene and protein expression in human leukocytes. | 2003-11-01 |
|
| In vitro evaluation of chemopreventive agents using cultured human prostate epithelial cells. | 2003-10-10 |
|
| Selenium and breast-feeding. | 2002-11 |
|
| Selenomethionine induction of DNA repair response in human fibroblasts. | 2002-05-23 |
|
| Micronutrients in cancer chemoprevention. | 2002 |
|
| [Determination of the selenomethionine content in grain and human blood]. | 1997-03 |
|
| [Method of analysis of regional dynamics of the pancreas with 75Se-selenomethionine]. | 1977-04 |
|
| 75Se-selenomethionine excretion in bile and pancreatic juice. | 1975 |
|
| Count rate analysis as an adjunct to the 75Se-selenomethionine pancreas scan. | 1969-10 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12398336
10 or 50 uM selenomethionine protects against cadmium toxicity in cultured K-562 cells.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:35:58 GMT 2025
by
admin
on
Mon Mar 31 18:35:58 GMT 2025
|
| Record UNII |
964MRK2PEL
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
2384 (Number of products:20)
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
||
|
DSLD |
2033 (Number of products:7)
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
||
|
NCI_THESAURUS |
C275
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/16/1782
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SELENOMETHIONINE
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | |||
|
62621
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | |||
|
C2833
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | |||
|
CHEMBL113178
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | |||
|
D012645
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | |||
|
DTXSID8046824
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | |||
|
964MRK2PEL
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | |||
|
30021
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | |||
|
3544
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | |||
|
DB11142
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | |||
|
105024
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | |||
|
1611955
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | |||
|
964MRK2PEL
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | |||
|
3211-76-5
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | |||
|
100000128771
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | |||
|
SUB36255
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | |||
|
9644
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | RxNorm | ||
|
m9848
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | Merck Index | ||
|
3211-76-5
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY | |||
|
760370
Created by
admin on Mon Mar 31 18:35:58 GMT 2025 , Edited by admin on Mon Mar 31 18:35:58 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
LABELED -> NON-LABELED |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |